Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 545,557 | 559,355 | 497,633 | 536,896 | 528,593 |
| Cost of Goods | 351,327 | 358,836 | 323,062 | 370,494 | 330,082 |
| Gross Profit | 194,230 | 200,519 | 174,571 | 166,402 | 198,511 |
| Operating Expenses | 150,204 | 399,973 | 151,328 | 155,721 | 170,078 |
| Operating Income | 44,353 | -198,618 | 23,305 | 11,175 | 28,515 |
| Interest Expense | 42,391 | 35,623 | 33,335 | 33,957 | 34,400 |
| Other Income | 218 | 1,510 | 109 | 6,463 | 3,842 |
| Pre-tax Income | 2,180 | -232,731 | -9,921 | -16,319 | -2,043 |
| Income Tax | 4,570 | 7,350 | -3,461 | 4,140 | 4,049 |
| Net Income Continuous | -2,390 | -240,081 | -6,460 | -20,459 | -6,092 |
| Minority Interests | 299 | -119,273 | -4,304 | -15,937 | N/A |
| Net Income | $-2,689 | $-120,808 | $-2,156 | $-4,522 | $-6,092 |
| EPS Basic Total Ops | -0.02 | -0.80 | -0.01 | -0.05 | -0.03 |
| EPS Basic Continuous Ops | -0.02 | -1.59 | -0.04 | -0.14 | -0.04 |
| EPS Diluted Total Ops | -0.02 | -0.80 | -0.01 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -1.59 | -0.04 | -0.13 | -0.04 |
| EBITDA(a) | $108,062 | $-136,729 | $83,315 | $74,688 | $91,101 |